BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 69 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $17,131,000 | -51.9% | 144,476 | -44.1% | 0.16% | -22.2% |
Q4 2021 | $35,623,000 | +2.5% | 258,497 | +3.3% | 0.20% | +12.8% |
Q3 2021 | $34,745,000 | +43.0% | 250,126 | -0.0% | 0.18% | +51.3% |
Q2 2021 | $24,293,000 | +34.9% | 250,238 | -5.0% | 0.12% | +22.7% |
Q1 2021 | $18,005,000 | +107.4% | 263,420 | +160.0% | 0.10% | +125.6% |
Q4 2020 | $8,683,000 | +31.2% | 101,307 | -0.5% | 0.04% | +4.9% |
Q3 2020 | $6,616,000 | -11.6% | 101,771 | -0.6% | 0.04% | -30.5% |
Q2 2020 | $7,483,000 | +115.3% | 102,352 | +0.2% | 0.06% | +40.5% |
Q1 2020 | $3,476,000 | +24.6% | 102,159 | +36.9% | 0.04% | +7.7% |
Q3 2017 | $2,790,000 | +44.6% | 74,637 | -3.3% | 0.04% | +34.5% |
Q2 2017 | $1,929,000 | – | 77,169 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 896,844 | $123,594,000 | 67.92% |
RP Management, LLC | 1,111,111 | $153,122,000 | 64.09% |
ORACLE INVESTMENT MANAGEMENT INC | 2,075,402 | $286,011,000 | 40.64% |
ARS Investment Partners, LLC | 463,392 | $63,860,000 | 5.86% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 300,373 | $41,394,000 | 4.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 80,348 | $11,073,000 | 4.49% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,900 | $19,282,000 | 4.30% |
Avidity Partners Management LP | 1,140,000 | $157,103,000 | 3.33% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $27,562,000 | 3.17% |
Eventide Asset Management | 1,635,000 | $225,319,000 | 2.88% |